CAS NO: | 1037792-44-1 |
规格: | ≥98% |
包装 | 价格(元) |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
250mg | 电议 |
MBX-2982 (SAR-260093) is a novel, potent, selective and orally bioavailable G protein-coupled receptor 119 (GPR119) agonist with the potential for treating type 2 diabetes. Preclinical data indicate that MBX-2982 is a potent selective orally -active GPR119 agonist that functions through a unique dual mechanism of action. First, it acts directly on the beta cell to increase insulin secretion. In addition, MBX-2982 stimulates release of the incretin GLP-1 from the gut. This dual action is unique and may offer improved glucose homeostasis over existing diabetes therapies, with potential for weight loss and improved islet health.
纯度:≥98%
CAS:1037792-44-1